Polycystic ovary syndrome is a hormonal disorder observed in females of reproductive ages. The disorder causes the excessive production of hormones in the female body, which include testosterone or androgens, hormones that are primarily associated with the male reproductive system. PCOS includes a range of symptoms such as irregular menstrual cycle, trouble in getting pregnant, cyst formation in the ovaries, excessive body and facial hair, and pelvic pain, among others.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/pcos-polycystic-ovary-syndrome-market
Moreover, the early diagnosis of the disorder is highly recommended by the physicians, as untreated PCOS may often lead to high cholesterol, type-2 diabetes, heart disease, insulin resistance, and high blood pressure. Major factors contributing to the growth of the global polycystic ovary syndrome market include sedentary lifestyle and faulty dietary habits and increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth.
A Full Report of Polycystic Ovary Syndrome (PCOS) Market is Available at: https://www.omrglobal.com/industry-reports/pcos-polycystic-ovary-syndrome-market
The polycystic ovary syndrome market can be segmented on the basis of drug type, diagnosis type, treatment type, and distribution channel. Based on drug type, the market is segmented into diuretics, insulin sensitizing agents, antiandrogens, anti-depressants, ornithine decarboxylase inhibitors, anti-obesity, and oral contraceptive pills. Based on diagnosis type, the market is bifurcated into ultrasound, pelvic exam, and blood tests. Based on treatment type, the market is segmented into ovarian wedge resection, laparoscopic ovarian drilling, and acupuncture. Based on distribution channel, the market is diversified into hospital pharmacies, drug stores, retail pharmacies, fertility clinics, and e-commerce
Some of the key players operating in the global polycystic ovary syndrome market are Abbott Laboratories, Bayer AG, AstraZeneca, Novartis, Glaxosmithkline plc, Teva Pharmaceuticals, and Furocyst, among others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development and so on.
MARKET SEGMENTATION
GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DRUG TYPE
• DIURETICS
• INSULIN SENSITIZING AGENTS
• ANTIANDROGENS
• ANTI-DEPRESSANTS
• ORNITHINE DECARBOXYLASE INHIBITORS
• ANTI-OBESITY
• ORAL CONTRACEPTIVE PILLS
GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DIAGNOSIS TYPE
• ULTRASOUND
• PELVIC EXAM
• BLOOD TEST
GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY TREATMENT TYPE
• OVARIAN WEDGE RESECTION
• LAPAROSCOPIC OVARIAN DRILLING
• ACUPUNCTURE
GLOBAL POLYCYSTIC OVARY SYNDROME MARKET BY DISTRIBUTION CHANNEL
• HOSPITAL PHARMACIES
• RETAIL PHARMACIES (ONLINE AND OFFLINE)
• FERTILITY CLINICS
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pcos-polycystic-ovary-syndrome-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404